Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

The coronavirus recombination pathway

Cell Host & Microbe(2023)10.1016/j.chom.2023.05.003Source: DataRank Database

The coronavirus recombination pathway is a research paper published in Cell Host & Microbe (2023). On theSindex it has a DataRank of 0. It has been cited 73 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access73 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 13.48)OA: hybridTopics (59)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (6)

Cassandra M. Bonavita ORCID,Isamara Navarrete‐Macias,Blake Vilchez,Angela L. Rasmussen ORCID,Simon J. Anthony ORCID

Live enrichment

PubMed:37321171 PMC:PMC10265781 OpenAlex:https://openalex.org/W4380853846

NIAID NIH HHS

Grant: R01 AI149693

National Institutes of Health

Grant: 1R01AI149693-01

Genetic and ecological determinants of coronavirus recombination

National Science Foundation

Grant: 2200221

PIPP Phase I: Transdisciplinary Innovation in Predictive Science for Emerging Infectious Disease and Spillover

FWCI

13.48

Citation Percentile

1.0%

Citation Trend

2023

2024

2025

2026

hybridLicense: cc-by-nc-nd

journalhttp://www.cell.com/article/S1931312823001968/pdf

publisherhttp://www.cell.com/article/S1931312823001968/pdf

publisherhttps://api.elsevier.com/content/article/PII:S1931312823001968?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1931312823001968?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.chom.2023.05.003

Fields of Study

SARS-CoV-2 and COVID-19 ResearchCRISPR and Genetic EngineeringEvolution and Genetic Dynamics0301 basic medicine03 medical and health sciences

MeSH Terms

COVID-19SARS-CoV-2HumansPhylogenyRecombination, GeneticRetrospective Studies

Keywords

RecombinationBiologyCoronavirusMechanism (biology)Homologous recombinationRecombinant DNATransmission (telecommunications)GenomeFLP-FRT recombinationComputational biologyCoronavirus disease 2019 (COVID-19)GeneticsEvolutionary biologyGenetic recombinationGeneComputer sciencePhysicsDiseaseEvolutionSpilloverpathwayBarriersCross-species TransmissionCoronavirusesImmunologybats610bat612ReviewMicrobiologyGeneticChiroptera2.2 Factors relating to the physical environmentHumansAnimaliaChordataPhylogenyRetrospective StudiesRecombination, GeneticSARS-CoV-2COVID-19BiodiversityBiological SciencesMedical microbiologyBiochemistry and cell biologyMammaliaBiotechnology

Sustainable Development Goals

SDG 0: Good health and well-being